Did Scientists Really Bring Back the Dire Wolf?
Last updated 19 August 2026 · 6 min read
Direct Answer
In April 2025, Colossal Biosciences announced it had produced three living pups, named Romulus, Remus, and Khaleesi, by making roughly 20 edits across 14 genes in grey wolf cells, drawing on ancient dire wolf DNA recovered from a 13,000-year-old tooth and a 72,000-year-old skull fragment. Colossal calls this de-extinction. Most paleogeneticists disagree, pointing out that the dire wolf (Aenocyon dirus) diverged from the grey wolf lineage roughly 5.7 million years ago, and that changing 14 genes out of roughly 19,000 in a grey wolf genome produces a grey wolf with some dire-wolf-like traits, not a resurrected member of a distinct, extinct species. Both sides agree on the underlying genetics; the dispute is about whether a small number of trait-altering edits should count as bringing a species back, or as creating something new.
Background
The dire wolf (Aenocyon dirus) was a large predatory canid that ranged across North America during the Pleistocene, going extinct around 13,000 years ago alongside much of the continent's Ice Age megafauna, including mammoths and sabre-toothed cats. It was long assumed to be a close relative of the grey wolf, similar enough that early classifications placed it in the same genus, Canis. A 2021 genome study published in Nature, led by paleogeneticist Angela Perri, overturned that assumption: comparing ancient DNA from five dire wolf specimens against living canids, the study found the dire wolf lineage split from the ancestors of grey wolves, coyotes, and African wild dogs roughly 5.7 million years ago, and detected no meaningful evidence of interbreeding between dire wolves and those other lineages since. The authors reclassified the dire wolf into its own genus, Aenocyon, meaning its resemblance to grey wolves is now understood as convergent evolution, two lineages independently arriving at a similar large, pack-hunting body plan, rather than close cousinhood.
That reclassification is the genetic backdrop against which Colossal Biosciences, a Texas-based de-extinction company, announced on 7 April 2025 that it had produced three living dire wolf pups: two males, Romulus and Remus, born in October 2024, and a female, Khaleesi, born in January 2025. The announcement, accompanied by a Time magazine cover and extensive media coverage, described the animals as the world's first successfully de-extincted species.
The Claimed Method
Colossal's team sequenced ancient DNA from two dire wolf specimens, a roughly 13,000-year-old tooth found in Ohio and a roughly 72,000-year-old skull fragment from Idaho, and compared it against modern grey wolf genomes to identify genetic differences associated with dire wolf traits. Rather than attempting to reconstruct a full dire wolf genome from scratch, which current ancient-DNA technology cannot yet do reliably from degraded prehistoric samples, the company's scientists made a targeted set of edits, roughly 20 changes across 14 genes, to grey wolf genomic cells, altering traits including body size, skull and jaw width, coat thickness, and a pale coat colour Colossal has linked to dire wolves' inferred pigmentation. The edited cells were then used to create embryos carried to term by domestic dog surrogates.
Colossal has been explicit that the pups' genomes remain overwhelmingly grey wolf. A grey wolf genome contains on the order of 19,000 protein-coding genes; the edited genes represent a small fraction of that total. The company's position is that these particular genes are the ones responsible for the visible and behavioural traits that define "dire wolf" as a category, and that recreating those traits in a living animal constitutes a meaningful, if partial, act of de-extinction.
The Scientific Dispute
The dispute among scientists is not primarily about the underlying laboratory work, which most experts accept was executed competently, but about the word Colossal has attached to it. Critics, including several paleogeneticists who were not involved in the project, argue that an animal whose genome is over 99.9% grey wolf, with a small number of trait-altering edits layered on top, is more accurately described as a genetically modified grey wolf than as a resurrected member of a species that diverged from wolves nearly six million years ago. Nic Rawlence, a New Zealand paleogeneticist, and other researchers have made this point publicly: species identity, in the conventional biological sense, rests on shared ancestry and reproductive lineage, not on a checklist of surface traits, and editing a handful of genes for appearance does not restore that lineage.
Colossal's own chief science officer, Beth Shapiro, an ancient-DNA researcher whose peer-reviewed work on extinct species predates her role at the company, has publicly acknowledged that the disagreement is largely definitional rather than factual. In interviews following the announcement, she has argued that "de-extinction" was never meant to imply an exact, unmodified genetic clone of an extinct animal, since that is not technically achievable with degraded ancient DNA, and that Colossal's functional approach, restoring the traits that made a species recognisably itself, is a legitimate and disclosed version of the concept rather than a misrepresentation of the science. Critics counter that stretching the definition that far makes it possible to call almost any sufficiently edited animal "de-extinct," which is precisely why they think the label matters.
How This Compares to Colossal's Other Projects
The dire wolf announcement sits alongside Colossal's other headline de-extinction programmes, for the thylacine and the woolly mammoth, but differs from them in an important respect: it is the only one of the three the company has claimed to have completed, in the sense of producing living animals, as of 2026. The thylacine project remains at the cell-line and embryonic-development stage, with no living animal yet produced, which is part of why the dire wolf claim drew disproportionately more scrutiny: it is the test case for whether Colossal's functional-restoration approach will be treated by the scientific community, and eventually by conservation and taxonomic authorities, as a genuine category of achievement or as an aggressive rebranding of conventional genetic engineering.
Current Consensus
There is no dispute that Colossal Biosciences produced three living grey wolf pups carrying a targeted set of gene edits associated with dire wolf traits, or that the underlying ancient-DNA and gene-editing techniques involved are real and scientifically sound. What remains contested is purely definitional: most paleogeneticists and conservation biologists who have commented publicly consider "de-extinction" a mischaracterisation of an animal whose genome remains almost entirely grey wolf, while Colossal maintains that restoring a target set of defining traits is a legitimate, if partial, form of the concept. No peer-reviewed taxonomic body has classified the pups as Aenocyon dirus, and the animals are, by standard genetic criteria, grey wolves.
Why the Debate Persists
The dire wolf debate endures because it sits at a genuinely new frontier where existing scientific vocabulary has not caught up with the technology. "De-extinction" was coined before gene-editing tools like CRISPR made partial, trait-targeted genetic modification practical at this scale, and no scientific body has yet formally defined how many edits, or which kind, a genome needs before a claim like Colossal's should be accepted or rejected. That vacuum leaves room for a well-funded company to set the terms of its own achievement in the media before the scientific community has settled on a shared standard for evaluating it.
The story also endures because it arrived with an emotionally resonant hook: dire wolves are widely known from popular culture, particularly as a fictional element of Game of Thrones, which Colossal's own marketing explicitly referenced, giving an otherwise technical genomics story an unusually large public audience. That combination of genuine scientific novelty, an unresolved definitional dispute among credentialed experts, and a pop-culture-primed audience is likely to keep the story, and the underlying question of what "bringing back" an extinct species should actually mean, alive well beyond the initial 2025 news cycle. This page is part of this site's biology and origins of life hub, itself part of the broader scientific theories and frontiers coverage.
Frequently Asked Questions
- How closely related are dire wolves and grey wolves?
- Less closely than their similar size and appearance suggest. A 2021 ancient-DNA study published in Nature found that dire wolves and grey wolves last shared a common ancestor around 5.7 million years ago, and that dire wolves belong to a distinct lineage with no significant interbreeding with grey wolves, coyotes, or other living canids. The study's authors reclassified the dire wolf into its own genus, Aenocyon, rather than the Canis genus grey wolves belong to. Their resemblance is convergent evolution: two large pack-hunting canids independently evolving similar body plans to fill similar ecological roles, not close cousins.
- What genes did Colossal Biosciences actually edit?
- Colossal has stated its team made roughly 20 edits across 14 genes in grey wolf genomic cells, targeting traits associated with dire wolves in the ancient-DNA record: a larger body size, a wider skull and jaw, thicker fur, and a pale coat colour. A grey wolf genome contains on the order of 19,000 protein-coding genes, so the edited genes represent a small fraction of the animals' total genetic makeup, which sits at the centre of the scientific dispute over what to call the result.
- Is Colossal Biosciences a credible scientific organisation?
- Colossal is a real, well-funded biotechnology company (valued at over $10 billion as of 2025) with a genuine scientific team, including CSO Beth Shapiro, an ancient-DNA researcher with a substantial peer-reviewed publication record predating her role at Colossal. Its underlying genetic engineering work is not in dispute among scientists; what is disputed is the company's own marketing language, describing the result as de-extinction rather than genetic modification of an existing species, which most conservation biologists and paleogeneticists consider a definitional overreach rather than a factual misrepresentation of the lab work itself.
References
Connected to
How this topic links to the people, places, and ideas around it — drawn from our knowledge graph.
Places
Colossal Biosciences is located in United States.
Thylacine is located in Australia.
Creatures & Figures
Thylacine is frequently compared to Coelacanth — Both are cited in 'Lazarus species' discussions, though the coelacanth's survival was confirmed by a physical specimen while the thylacine's remains statistically disputed.
Thylacine is frequently compared to Ivory-Billed Woodpecker — Both are the site's flagship 'Lazarus species' cases, with near-identical last-confirmed-sighting dates in the 1940s and ongoing statistical extinction-date disputes.
- New Zealand Fiordland Mooseintroduced 1910, last confirmed 2005
Thylacine is frequently compared to New Zealand Fiordland Moose — Both are cited as candidate "Lazarus species" cases, though the moose is confirmed to have existed within living memory while the thylacine has not been confirmed alive since 1936.
Related Questions
Did Homo Naledi Really Bury Its Dead and Carve Cave Art?
In 2023, researchers claimed a small-brained human relative buried its dead and carved cave art. Other palaeoanthropologists say the evidence falls short.
Is the Tasmanian Tiger Really Extinct?
Is the Tasmanian tiger really extinct? The 1936 last captive death, the 2017 and 2023 statistical models, and Colossal Biosciences' de-extinction project.
Did Moose Survive in New Zealand's Fiordland?
Did moose survive in New Zealand's Fiordland? DNA-confirmed hair from 2001-02, decades of searching, and why DOC still calls the population extinct.
What Is Abiogenesis?
Abiogenesis explained: the leading scientific hypotheses for how life could have arisen from non-living chemistry, and why the question remains open.
How Did the Coelacanth Come Back From the Dead?
How the coelacanth, thought extinct for 66 million years, was found alive in 1938: the discovery, the 1997 second species, and why it matters to cryptozoology.
What Is the Panspermia Hypothesis?
Panspermia explained: natural and directed panspermia, the Murchison meteorite evidence, and why most scientists see it as relocating, not solving, abiogenesis.